SCP-9984
Euclid
?
low confidence
SCP-9984
Expected annual
$491K
One-time setup
$1.1M
Annual recurring
$455K
Personnel
8
One-time capital (containment cell, equipment, and optional lab setup) ~ $1.09M; annual baseline operating costs ~ $455k/yr driven primarily by personnel, medication procurement, and administrative/monitoring overhead. Major cost uncertainty is anomalous drug production/procurement.
One-Time Capital Costs
Total: $1.1M
Annual Recurring Costs
Total: $455K/yr
Cost Scenarios
📊
Baseline
(baseline)
$455K/yr
Normal uneventful year excluding large-scale in-house diristocon production; standard monitoring, medication procurement (including clandestine/covered channels), maintenance, and staffing.
standard_operations
no_in-house_production
no_breach_or_major_incident
🚨
In House Diristocon Production
$855K/yr
Decision/need to produce diristocon in-house at scale, incurring substantial recurring operating, materials, QA, and specialist personnel costs.
procurement_blocked
scale_up_for_research
legal_risk_forced_internal_production
🚨
Major Breach
$655K/yr
Containment breach or significant incident requiring emergency response, overtime, equipment replacement, and legal/PR containment.
physical_breach
medical_emergency_requiring_extraction
public_exposure
Personnel
8 total
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 3 | Covers three-person interaction requirement; roles may be rotational or pooled. |
| CCTV Operator | 1 | 24/7 monitoring allocation (may be shared across multiple feeds). |
| Medical Officer (RN) | 1 | RN-level daily medication administration oversight (fractional FTE reflected in wages). |
| Physician (oversight) | 1 | Part-time physician oversight for prescriptions and emergencies (fractional FTE). |
| Psychologist | 1 | Weekly remote interviews and behavior monitoring; part-time allocation. |
| Administrative Staff | 1 | Ethical oversight, audits, records management and compliance administration. |
Confidence Notes
Most containment items (cell, cameras, staffing, daily services) are well-specified, but large uncertainties remain around anomalous drug (diristocon) production/procurement and controlled-substance (mescaline) handling; scenario probabilities are judgment-based.